| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $16.1M | $8.5M | $1.5M |
| YoY Revenue Growth % | +89.8% | +454.7% | — |
| Gross Profit | $4.5M | $905.6K | — |
| Gross Margin % | 27.8% | 10.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$18.8M | -$15.5M | -$14.7M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | $16.1M | $8.5M | $1.5M |
| EBITDA (Normalized) | -$18.2M | -$15.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$17.3M | -$10.1M | -$11.9M |
| Capital Expenditures (CapEx) | $789.5K | $528.2K | — |
| Free Cash Flow (FCF) | -$18.1M | -$10.7M | -$11.9M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $5.9M | $4.9M | — |
| Total Debt (Short + Long Term) | $950.5K | — | — |
| Total Stockholders' Equity | $22.9M | $17.4M | — |